0001415889-23-000884.txt : 20230112
0001415889-23-000884.hdr.sgml : 20230112
20230112163929
ACCESSION NUMBER: 0001415889-23-000884
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230110
FILED AS OF DATE: 20230112
DATE AS OF CHANGE: 20230112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Almstead Neil Gregory
CENTRAL INDEX KEY: 0001578850
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 23526308
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
form4-01122023_090120.xml
X0306
4
2023-01-10
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001578850
Almstead Neil Gregory
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
false
true
false
false
CHIEF TECHNICAL OPS OFFICER
Common Stock
2023-01-10
4
S
0
473
42.9329
D
64962
D
Common Stock
2023-01-10
4
S
0
27
42.9329
D
3358
I
By Spouse
Common Stock
2023-01-11
4
S
0
383
44.3596
D
64579
D
Common Stock
2023-01-11
4
S
0
27
44.3596
D
3331
I
By Spouse
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 3,600 RSUs from a January 7, 2022 grant of 14,400 RSUs.
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 195 RSUs from a January 7, 2022 grant of 780 RSUs.
/s/ Avraham S. Adler, Attorney-in-Fact
2023-01-12